Skip to main content

$117M Asbestos Verdict Reversed By NJ Appeals Court

$117M Asbestos Verdict Reversed By NJ Appeals Court

$117M Asbestos Verdict Reversed By NJ Appeals Court

Introduction

New Jersey appeals court reversed the verdict of $117 million in a lawsuit that claimed a man developed mesothelioma due to the asbestos present in the talcum powder products of Johnson & Johnson (J&J) and Imerys Talc America.

Improper testimony and lack of evidence from the plaintiff's lawyers resulted in the dismissal of the verdict. According to the published panel opinion by the Appellate Division Judge Joseph L. Yannotti, the experts did not support the testimony acknowledged by a defense expert who claims that the talc used in the baby powder contains "non-asbestiform amphiboles."

It is one of the biggest victories for J&J and Imerys in litigation across the country, which claims that the company purposely used asbestos in the talc products causing cancer among the consumers. J&J even claimed that their talc products are safe by stating that it does not contain asbestos and does not cause cancer as per the scientific tests done for decades.

The plaintiffs filed a lawsuit under the New Jersey Products Liability Act against J&J and Imerys in December 2016, claiming that the company's talc products contain asbestos that contracted mesothelioma for them.

One of the plaintiffs' attorneys informed that they will appeal the case in the New Jersey Supreme Court, as the case was earlier tried in 2018 when the investigative journalist and the U.S. Food and Drug Administration provided scientific studies linking talcum powder usage to mesothelioma.

In April 2018, at the end of a more than two-month trial, the jury stated that the plaintiff's exposure to the asbestos present in the company's products caused his mesothelioma. He was even awarded $37 million as compensatory damages and $80 million in combined punitive damages. But a state appellate court overturned the award and ordered new trials in the case.

In May 2020, J&J stopped the sale of its baby powder in the U.S. and Canada as the demand for the products drastically declined due to the thousands of lawsuits claiming it has caused cancer.

All the asbestos-related lawsuits are consolidated under MDL No. 875, which was created in 1991 in the Eastern District of Pennsylvania.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Court Approves $700M Opioid Settlement for Acute Hospitals

Categories: Opioids

A federal court has approved a $700 million class-action settlement that will compensate over 1,000 acute care hospitals for costs related to the opioid crisis.

The settlement consolidates four separate agreements involving major drug…

Philips Settles CPAP Lawsuits Over Toxic Foam for $1.1B

Philips has been embroiled in legal battles following the recall of millions of CPAP, BiPAP, and ventilator devices due to toxic foam degradation.

The breakdown of the foam in these machines may release harmful chemicals, raising serious…

Texas Trial to Decide J&J’s $10B Talcum Powder Settlement

Categories: Talcum

A high-stakes trial in Texas will determine whether Johnson & Johnson (J&J) can resolve tens of thousands of talcum powder cancer lawsuits through a…

🎁 March VIP Medical Record Review Offer – Get 300 Pages Free!         
Includes a Free Life Care Plan Report + 10% Off Future Reviews!

Only 15 Firms Accepted.